Mary Ann Gray, Director at ACADIA PHARMACEUTICALS INC (ACAD), sold 15,000 shares at $20.71 ($310K) on 2013-08-26, disclosed to the SEC on 2013-08-28.
Scheduled sale ($310k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.62 | 5,000 | $103K | 33.2% |
| 2 | $20.71 | 10,000 | $207K | 66.8% |
| Total | $20.68 avg | 15,000 | $310K | 100% |
| Filing → |
| ACAD | SELL | 2014-12-17 | $389K | — | Filing → |
| GTCB | BUY | 2007-12-17 | $9K | — | Filing → |
| DYAX | BUY | 2006-05-19 | $29K | — | Filing → |